Kluge Andreas - 12 Nov 2024 SCHEDULE 13G Report for Telix Pharmaceuticals Ltd Ordinary Shares (TLX)

Filing Manager
Kluge Andreas
Reporting Manager
Kluge Andreas
Security
Telix Pharmaceuticals Ltd Ordinary Shares
Symbol
TLX
Shares outstanding
334,439,528 shares
Disclosed Ownership
22,675,000 shares
Ownership
6.78%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 07:00:08 UTC
Date of event
12 Nov 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kluge Andreas 6.78% 22,675,000 0 22,675,000 /s/ Dr. Andreas Kluge Dr. Andreas Kluge
Gnosis Verwaltungsgesellschaft m.b.H. 6.78% 22,675,000 0 22,675,000 /s/ Dr. Andreas Kluge Dr. Andreas Kluge, Managing Director